← back to search

Susan Landau

Mount Sinai Hospital · US
Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Functional Brain Connectivity Studies, and Medical Imaging Techniques and Applications.
h-index
51
citations
12,289
works
185
NIH funding
primary concept
email

Recent publications

Relationships of PGRN with sTREM2 in AD continuum and non-AD pathophysiology and their reciprocal roles in modulating amyloid pathology: two population-based study
Translational Psychiatry 2025cited by 3position: middledoi
Individuals with Alzheimer's disease and low tau burden: Characteristics and implications
Alzheimer s & Dementia 2024cited by 30position: firstdoi
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
Scientific Reports 2024cited by 26position: middledoi
The ADNI PET Core at 20
Alzheimer s & Dementia 2024cited by 23position: middledoi
Enhancing cognitive performance prediction by white matter hyperintensity connectivity assessment
Brain 2024cited by 15position: middledoi
The POINTER Imaging baseline cohort: Associations between multimodal neuroimaging biomarkers, cardiovascular health, and cognition
Alzheimer s & Dementia 2024cited by 12position: middledoi
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022
Alzheimer s & Dementia 2023cited by 93position: middledoi
Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction
Communications Medicine 2023cited by 69position: middledoi
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Nature Communications 2022cited by 129position: middledoi
Traumatic brain injury and post‐traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers
Alzheimer s & Dementia 2022cited by 48position: middledoi
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease
Nature Aging 2022cited by 46position: middledoi
Quantification of amyloid beta and tau PET without a structural MRI
Alzheimer s & Dementia 2022cited by 40position: firstdoi
The trend of disruption in the functional brain network topology of Alzheimer’s disease
Scientific Reports 2022cited by 40position: middledoi
Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
Alzheimer s & Dementia 2021cited by 184position: middledoi
A deep learning framework identifies dimensional representations of Alzheimer’s Disease from brain structure
Nature Communications 2021cited by 99position: middledoi
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease
Brain 2021cited by 93position: middledoi
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
Translational Psychiatry 2021cited by 68position: middledoi
Abnormal tau in amyloid PET negative individuals
Neurobiology of Aging 2021cited by 51position: middledoi
Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
Scientific Reports 2021cited by 31position: middledoi
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Nature Communications 2020cited by 534position: middledoi
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
The Lancet Neurology 2020cited by 515position: middledoi
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
Nature Communications 2020cited by 339position: middledoi
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology
Scientific Reports 2020cited by 134position: middledoi
Normalization of CSF pTau measurement by Aβ40 improves its performance as a biomarker of Alzheimer’s disease
Alzheimer s Research & Therapy 2020cited by 66position: middledoi
FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease
Nature Communications 2020cited by 32position: middledoi
A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease
Scientific Reports 2020cited by 20position: middledoi
Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults
JAMA Neurology 2019cited by 368position: middledoi
Non-coding variability at the APOE locus contributes to the Alzheimer’s risk
Nature Communications 2019cited by 123position: middledoi
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
Nature Communications 2019cited by 114position: middledoi
Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics
Scientific Reports 2019cited by 93position: middledoi

Grants

Collaborative Research: Conference: Workshop on Advanced Automated Systems, Contestability, and the Law
NSF2349803$70,3992023–2024PIRePORTER
EAGER: Understanding and Categorizing Metadata
NSF1923528$290,2072019–2023PIRePORTER
POWRE: Certification of Security Protocols
NSF9753055$66,4571997–1999PIRePORTER
International Symposium in Symbolic and Algebraic Computation; Kiev, Ukraine; July 1993
NSF9306948$9,3001993–1994PIRePORTER
Algebraic Algorithms
NSF9204630$150,6011992–1995PIRePORTER
Mathematical Sciences: Postdoctoral Research Fellowship
NSF8807202$74,1001988–1992PIRePORTER
RUI: Algebraic Algorithms Computational Complexity
NSF8802835$22,1051988–1989PIRePORTER
Algebraic Algorithms and Computational Complexity (Computer Research)
NSF8402173$34,5091984–1986PIRePORTER

Frequent collaborators

William J. Jagust · Berkeley College11 papers (2012–2024)Michael W. Weiner · Hôpital Beau-Séjour7 papers (2015–2024)Clifford R. Jack · ADS Group5 papers (2015–2023)Danielle Harvey · University of California, Berkeley5 papers (2017–2024)Leslie M. Shaw · Siemens (United States)5 papers (2015–2023)Duygu Tosun · Ministry of Health4 papers (2017–2024)John Q. Trojanowski · University of Pennsylvania4 papers (2015–2022)Andrew J. Saykin · Vanderbilt University Medical Center4 papers (2017–2023)Ronald C. Petersen · University Hospital Leipzig4 papers (2017–2023)Robert A. Koeppe · Johannes Kepler University of Linz4 papers (2015–2024)Dallas P. Veitch · University of California, San Francisco4 papers (2017–2023)Paul Aisen · University of Southern California4 papers (2017–2023)Renaud La Joie · University Memory and Aging Center3 papers (2020–2022)Gil D. Rabinovici · Harvard University3 papers (2013–2024)Suzanne L. Baker · Lawrence Berkeley National Laboratory3 papers (2021–2024)Theresa M. Harrison · University of California, Berkeley3 papers (2022–2024)Tyler J. Ward · University of California, Berkeley3 papers (2021–2024)Richard J. Perrin · Maine Farmland Trust2 papers (2021–2023)Deniz Korman · University of California, Berkeley2 papers (2020–2021)Arthur W. Toga · UtopiaCompression (United States)2 papers (2021–2023)